October [ ], 2020 ANIXA BIOSCIENCES, INC. WARRANT TO PURCHASE SHARES OF COMMON STOCKWarrant Agreement • January 7th, 2021 • Anixa Biosciences Inc • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 7th, 2021 Company Industry JurisdictionThis Warrant is issued to ACORN MANAGEMENT PARTNERS, L.L.C. (the “Holder”) by ANIXA BIOSCIENCES, INC., a Delaware corporation (the “Company”), pursuant to the terms of that certain Professional Relations and Consulting Agreement, dated as of October [ ], 2020, by and among the Company and the Holder (the “Agreement”).
Redactions with respect to certain portions hereof denoted with “***” EXCLUSIVE LICENSE AGREEMENT between THE CLEVELAND CLINIC FOUNDATION and ANIXA BIOSCIENCES, INC. dated as of October 20, 2020Exclusive License Agreement • January 7th, 2021 • Anixa Biosciences Inc • Pharmaceutical preparations • Ohio
Contract Type FiledJanuary 7th, 2021 Company Industry Jurisdiction
AMENDMENT TO COLLABORATION AGREEMENTCollaboration Agreement • January 7th, 2021 • Anixa Biosciences Inc • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 7th, 2021 Company Industry JurisdictionThis AMENDMENT TO COLLABORATION AGREEMENT (the “Amendment”) is made as of October 19, 2020 (the “Amendment Effective Date”), by and between Anixa Biosciences, Inc., a Delaware corporation (“Anixa”), and OntoChem GmbH, a German limited liability company (“OntoChem”). Anixa and OntoChem are referred to herein individually as a “Party” and collectively as the “Parties.”
Redactions with respect to certain portions hereof denoted with “***” AMENDMENT 2 TO THE COLLABORATION AGREEMENT BETWEEN CERTAINTY THERAPEUTICS, INC. ANDCollaboration Agreement • January 7th, 2021 • Anixa Biosciences Inc • Pharmaceutical preparations
Contract Type FiledJanuary 7th, 2021 Company IndustryThe “Agreement” described above was previously entered into on November 17, 2017 (hereinafter “Effective Date) and duly amended on July 24, 2019 (“Amendment 1 Effective Date”) by and between H. Lee Moffitt Cancer Center and Research Institute, Inc. a non-profit Florida corporation organized pursuant to Section 1004.43, Florida Statutes, whose address is 12902 Magnolia Drive, Tampa, Florida 33612 (“Moffitt”) and Certainty Therapeutics, Inc., a corporation duly organized under the laws of Delaware whose address is 3150 Almaden Expressway, Suite 250, San Jose, California 95118 (hereinafter “Company”). Moffitt and Company are hereinafter referred to individually as “Party” and collectively as “Parties.”